RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aion Therapeutic Stock

Aion Therapeutic P/S 2024

Aion Therapeutic P/S

0

Ticker

AION.CN

ISIN

CA00905T1021

WKN

A2QCBY

As of Sep 26, 2024, Aion Therapeutic's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Aion Therapeutic P/S history

Aion Therapeutic Aktienanalyse

What does Aion Therapeutic do?

Aion Therapeutic Inc is a Canadian company specializing in the development of medications derived from cannabis and the research of these compounds. The company was founded in 2017 and has been operating on the Toronto Stock Exchange under the ticker symbol AION. The goal of Aion Therapeutic is to advance the development of innovative therapies based on the medical application of cannabinoids. The company focuses on discovering and testing medications that not only have high efficacy but also have a lower risk of side effects. Aion Therapeutic's business model is built on several pillars. This includes research and development of medications based on cannabis compounds such as CBD and THC. The company works closely with experts in the field of science and cannabinoid pharmaceutical production. Another important area is the distribution of cannabis products, such as seeds, oils, extracts, and dried flowers. The company utilizes innovative technologies and processes to improve the quality and effectiveness of these products. In terms of its business activities, Aion Therapeutic can be divided into different areas. One of the most important is the development of medications based on cannabis extract chemotypes that can be used for the prevention and treatment of diseases such as pain, inflammation, chronic conditions, and neurological disorders. The company collaborates closely with leading research institutes and universities worldwide to focus on developing methods that improve the effectiveness and safety of these products. Aion Therapeutic is also active in the manufacturing and marketing of cannabis products. The company offers high-quality cannabinoid extracts from different hemp varieties, specifically tailored to meet the needs of medical users. These products aim to enhance users' well-being and alleviate symptoms of chronic conditions. Another important area of Aion Therapeutic is the application of cannabis-based products in veterinary medicine. The company focuses on developing veterinary medicines specifically designed for pets such as dogs and cats. Similar to the medical application of CBD and THC in humans, the use in veterinary medicine aims to alleviate chronic pain and inflammation or enhance well-being. In summary, Aion Therapeutic is a company specializing in the development of cannabis-based medications and products. With a focus on new technologies and research findings, the company aims to improve the medical application of CBD and THC and establish them as a credible alternative to conventional medications. Aion Therapeutic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Aion Therapeutic's P/S Ratio

Aion Therapeutic's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Aion Therapeutic's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Aion Therapeutic's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Aion Therapeutic’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Aion Therapeutic stock

What is the price-to-earnings ratio of Aion Therapeutic?

The price-earnings ratio of Aion Therapeutic is currently 0.

How has the price-earnings ratio of Aion Therapeutic changed compared to last year?

The price-to-earnings ratio of Aion Therapeutic has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Aion Therapeutic high compared to other companies?

Yes, the price-to-earnings ratio of Aion Therapeutic is high compared to other companies.

How does an increase in the price-earnings ratio of Aion Therapeutic affect the company?

An increase in the price-earnings ratio of Aion Therapeutic would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Aion Therapeutic affect the company?

A decrease in the price-earnings ratio of Aion Therapeutic would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Aion Therapeutic?

Some factors that influence the price-earnings ratio of Aion Therapeutic are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Aion Therapeutic pay?

Over the past 12 months, Aion Therapeutic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aion Therapeutic is expected to pay a dividend of 0 CAD.

What is the dividend yield of Aion Therapeutic?

The current dividend yield of Aion Therapeutic is .

When does Aion Therapeutic pay dividends?

Aion Therapeutic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aion Therapeutic?

Aion Therapeutic paid dividends every year for the past 0 years.

What is the dividend of Aion Therapeutic?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aion Therapeutic located?

Aion Therapeutic is assigned to the '-' sector.

Wann musste ich die Aktien von Aion Therapeutic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aion Therapeutic from 9/26/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Aion Therapeutic pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Aion Therapeutic in the year 2023?

In the year 2023, Aion Therapeutic distributed 0 CAD as dividends.

In which currency does Aion Therapeutic pay out the dividend?

The dividends of Aion Therapeutic are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aion Therapeutic

Our stock analysis for Aion Therapeutic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aion Therapeutic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.